sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Rnai Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00007157
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

RNAi Therapeutics Market Scope and Analysis by 2031

Buy Now

RNAi Therapeutics Market Report RNAi Therapeutics Market Size and Share RNAi Therapeutics Market Scope and Analysis

RNAi Therapeutics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 1.5 Billion
Market Size by 2031 US$ 3.2 Billion
Global CAGR (2023 - 2031) 16.5%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Molecule Type
  • Small Interfering RNAs
  • MicroRNA
By Application
  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular
  • Respiratory Disorders
  • Infectious Diseases
  • Renal Diseases
By Route of Administration
  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections
  • Intraperitoneal Injections
By End User
  • Diagnostic Laboratories
  • Research & Academic Laboratories
  • Hospitals
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Alnylam Pharmaceuticals Inc
  • Sanofi
  • Olix Pharmaceuticals Inc
  • GlaxoSmithKline Plc
  • Benitec Biopharma
  • Arbutus Biopharma Corporation
  • Silence Therapeutics
  • Rexahn Pharmaceuticals Inc
  • Arrowhead Pharmaceuticals Inc
  • Quark